Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.
Saved in:
| Title: | Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial. |
|---|---|
| Authors: | Budde LE; City of Hope, Duarte, CA., Zhang H; Tianjin Medical University Cancer Institute, Tianjin, China., Kim WS; Samsung Medical Center, Seoul, Republic of Korea., Maruyama D; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Rego EM; Instituto D'Or de Pesquisa e Ensino, São Paulo, Brazil., Norasetthada L; Chiang Mai University, Chiang Mai, Thailand., Hong H; Si Chuan Cancer Hospital, Chengdu, China., Ozcan M; Ankara University School of Medicine, Ankara, Turkey., Jeon YW; Yeouido St Mary's Hospital, Seoul, Republic of Korea., Leão Cordeiro de Farias D; Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Fogliatto LM; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Pavlovsky A; Fundaleu, Buenos Aires, Argentina., Goto H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Olszewski AJ; Brown University, Providence, RI., Shah N; Tampa General Hospital Cancer Institute, Tampa, FL., Hu B; Atrium Health Levine Cancer Institute and Wake Forest School of Medicine, Charlotte, NC., Yin S; Genentech, Inc, South San Francisco, CA., Wu H; Genentech, Inc, South San Francisco, CA., To I; Genentech, Inc, South San Francisco, CA., Ead WS; Genentech, Inc, South San Francisco, CA., Ashby J; Genentech, Inc, South San Francisco, CA., Janousek M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Pham S; Hoffmann-La Roche Ltd, Mississauga, ON, Canada., Wang J; Genentech, Inc, South San Francisco, CA., Kwan A; Genentech, Inc, South San Francisco, CA., Batlevi CL; Genentech, Inc, South San Francisco, CA., Wei MC; Genentech, Inc, South San Francisco, CA., Westin J; MD Anderson Cancer Center, Houston, TX. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Dec 20; Vol. 43 (36), pp. 3799-3811. Date of Electronic Publication: 2025 Oct 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
